Merck | Patient Daily

Merck

Carol Ostrow | May 16, 2018

FDA accepts two new drug applications for Merck HIV-1 therapy

Marian Johns | Jan 17, 2018

FDA approves Lynparza as first PARP Inhibitor for treating metastatic breast cancer

Carol Ostrow | Jan 7, 2018

Merck, Pfizer Type 2 diabetes treatments gain FDA approval

Carol Ostrow | Oct 15, 2017

Merck KGaA aims raise awareness, boost support for unpaid caregivers

Carol Ostrow | Oct 1, 2017

Merck to host meeting on third-quarter performance

Russell Boniface | Sep 13, 2017

Merck's Keytruda wins European approval as bladder cancer treatment

Robert Hadley | Jun 16, 2017

Merck’s Keytruda shown effective in treating aggressive form of breast cancer

Tabitha Fleming | Jun 2, 2017

Merck's Keytruda approved for treating Hodgkin's lymphoma in Europe

Trending

Patient Daily News Service | Jan 22, 2025

National Pharmacists Group to DOGE: Start search for 'waste and inefficiencies in federal programs' with the pharmacy benefit managers

+ Pharmaceuticals

Patient Daily | Jan 17, 2025

Understanding symptoms and treatment options for long-term effects of COVID-19

Patient Daily News Service | Jan 16, 2025

FTC Chair: Report Finds 'Three Major Pharmacy Benefit Managers Hiked Costs for a Wide Range of Lifesaving Drugs, Including Medications to Treat Heart Disease and Cancer'